These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 11513562)

  • 1. Solitary cancer cells as a possible source of tumour dormancy?
    Naumov GN; MacDonald IC; Chambers AF; Groom AC
    Semin Cancer Biol; 2001 Aug; 11(4):271-6. PubMed ID: 11513562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy.
    Naumov GN; MacDonald IC; Weinmeister PM; Kerkvliet N; Nadkarni KV; Wilson SM; Morris VL; Groom AC; Chambers AF
    Cancer Res; 2002 Apr; 62(7):2162-8. PubMed ID: 11929839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site.
    Kauffman EC; Robinson VL; Stadler WM; Sokoloff MH; Rinker-Schaeffer CW
    J Urol; 2003 Mar; 169(3):1122-33. PubMed ID: 12576866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer micrometastasis and tumour dormancy.
    Wikman H; Vessella R; Pantel K
    APMIS; 2008; 116(7-8):754-70. PubMed ID: 18834417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metastatic process: basic research and clinical implications.
    Chambers AF
    Oncol Res; 1999; 11(4):161-8. PubMed ID: 10566614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular interactions in the vascular niche: implications in the regulation of tumor dormancy.
    Favaro E; Amadori A; Indraccolo S
    APMIS; 2008; 116(7-8):648-59. PubMed ID: 18834409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor dormancy of primary and secondary cancers.
    Udagawa T
    APMIS; 2008; 116(7-8):615-28. PubMed ID: 18834406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged dormancy and site-specific growth potential of cancer cells spontaneously disseminated from nonmetastatic breast tumors as revealed by labeling with green fluorescent protein.
    Goodison S; Kawai K; Hihara J; Jiang P; Yang M; Urquidi V; Hoffman RM; Tarin D
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3808-14. PubMed ID: 14506175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor cell dormancy: implications for the biology and treatment of breast cancer.
    Fehm T; Mueller V; Marches R; Klein G; Gueckel B; Neubauer H; Solomayer E; Becker S
    APMIS; 2008; 116(7-8):742-53. PubMed ID: 18834416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential steps in hematogenous metastasis of cancer cells studied by in vivo videomicroscopy.
    Morris VL; Schmidt EE; MacDonald IC; Groom AC; Chambers AF
    Invasion Metastasis; 1997; 17(6):281-96. PubMed ID: 9949288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling growth kinetics and statistical distribution of oligometastases.
    Withers HR; Lee SP
    Semin Radiat Oncol; 2006 Apr; 16(2):111-9. PubMed ID: 16564446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New clinical and experimental approaches for studying tumor dormancy: does tumor dormancy offer a therapeutic target?
    Goss P; Allan AL; Rodenhiser DI; Foster PJ; Chambers AF
    APMIS; 2008; 116(7-8):552-68. PubMed ID: 18834402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization.
    Riethdorf S; Pantel K
    Pathobiology; 2008; 75(2):140-8. PubMed ID: 18544969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of disseminated tumour cells as a potential surrogate-marker for monitoring palliative chemotherapy in colorectal cancer patients.
    Staritz P; Kienle P; Koch M; Benner A; von Knebel Doeberitz M; Rudi J; Weitz J
    J Exp Clin Cancer Res; 2004 Dec; 23(4):633-9. PubMed ID: 15743034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tumor dormancy and identification of therapeutic targets].
    Li CF; Cao S; Meng SD
    Ai Zheng; 2009 May; 28(5):555-8. PubMed ID: 19624889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour dormancy: findings and hypotheses from clinical research on breast cancer.
    Demicheli R
    Semin Cancer Biol; 2001 Aug; 11(4):297-306. PubMed ID: 11513565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour dormancy: initiation, maintenance and termination in animals and humans.
    Stewart TH; Hollinshead AC; Raman S
    Can J Surg; 1991 Aug; 34(4):321-5. PubMed ID: 1868387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The direct molecular analysis of metastatic precursor cells in breast cancer: a chance for a better understanding of metastasis and for personalised medicine.
    Klein CA
    Eur J Cancer; 2008 Dec; 44(18):2721-5. PubMed ID: 19022661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer metastasis: advances in the detection and characterization of disseminated tumour cells facilitate clinical translation.
    Balic M; Dandachi N; Lin H; Datar RH
    Natl Med J India; 2005; 18(5):250-5. PubMed ID: 16433139
    [No Abstract]   [Full Text] [Related]  

  • 20. Vascular determinants of cancer stem cell dormancy--do age and coagulation system play a role?
    Rak J; Milsom C; Yu J
    APMIS; 2008; 116(7-8):660-76. PubMed ID: 18834410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.